Search

everythinglearnresearchcommunity

for

Search:↓

Some minoxidil combinations can help differentiate leukemia cells without harming other cells.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Nanotechnology shows promise for better drug delivery and cancer treatment.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Some drugs used to treat immune conditions may cause different types of hair loss.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Vitamin D is important for bones, hair, blood pressure, and breast development.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Exosome therapy shows promise for treating skin conditions and improving wound healing.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Melanocytes are important for normal body functions and have potential uses in regenerative medicine and disease treatment.

Adding a second method to PROTACs could improve cancer treatment.

Bioinspired polymers are promising for advanced medical treatments and tissue repair.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.